294
Views
7
CrossRef citations to date
0
Altmetric
Meta-Opinion

Induction therapy for the management of early relapsing forms of multiple sclerosis. A critical opinion

, ORCID Icon &
Pages 1553-1556 | Received 30 Apr 2017, Accepted 08 Aug 2017, Published online: 22 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Aurora Zanghì, Emanuele D’Amico & Francesco Patti. (2020) Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment. Expert Review of Neurotherapeutics 20:8, pages 771-782.
Read now
A. Zanghì & E. D’Amico. (2019) New treatment targets in multiple sclerosis therapy. Expert Review of Precision Medicine and Drug Development 4:4, pages 201-203.
Read now

Articles from other publishers (5)

Itay Lotan, Esther Ganelin-Cohen, Evgeny Tartakovsky, Vadim Khasminsky, Mark A. Hellmann, Israel Steiner, Ilan Ben-Zvi, Avi Livneh, Sizilia Golderman & Batia Kaplan. (2020) Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosis. Multiple Sclerosis and Related Disorders 44, pages 102339.
Crossref
Itay LotanFelix Benninger, Rom MendelMark A. HellmannIsrael Steiner. (2019) Does CSF pleocytosis have a predictive value for disease course in MS?. Neurology Neuroimmunology & Neuroinflammation 6:5.
Crossref
Elizabeth R. Comini-Frota, Bruna C. C. Marques, Caio Torres, Karoline M. S. Cohen & Eduardo Carvalho Miranda. (2019) Nine-year follow up after hematopoietic stem cell transplantation in five multiple sclerosis patients. Arquivos de Neuro-Psiquiatria 77:8, pages 531-535.
Crossref
Katja AkgünNicole KretschmannRocco HaaseUndine ProschmannHagen H. KitzlerHeinz ReichmannTjalf Ziemssen. (2019) Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS. Neurology Neuroimmunology & Neuroinflammation 6:3.
Crossref
Serena Ruggieri, Simona Pontecorvo, Carla Tortorella & Claudio Gasperini. (2018) Induction treatment strategy in multiple sclerosis: a review of past experiences and future perspectives. Multiple Sclerosis and Demyelinating Disorders 3:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.